General Information of Drug Off-Target (DOT) (ID: OT6CMNSF)

DOT Name Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 (GNG3)
Synonyms Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3
Gene Name GNG3
UniProt ID
GBG3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00631
Sequence
MKGETPVNSTMSIGQARKMVEQLKIEASLCRIKVSKAAADLMTYCDAHACEDPLITPVPT
SENPFREKKFFCALL
Function
Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.
KEGG Pathway
Ras sig.ling pathway (hsa04014 )
Chemokine sig.ling pathway (hsa04062 )
PI3K-Akt sig.ling pathway (hsa04151 )
Apelin sig.ling pathway (hsa04371 )
Circadian entrainment (hsa04713 )
Retrograde endocan.binoid sig.ling (hsa04723 )
Glutamatergic sy.pse (hsa04724 )
Cholinergic sy.pse (hsa04725 )
Serotonergic sy.pse (hsa04726 )
GABAergic sy.pse (hsa04727 )
Dopaminergic sy.pse (hsa04728 )
Relaxin sig.ling pathway (hsa04926 )
Morphine addiction (hsa05032 )
Alcoholism (hsa05034 )
Human cytomegalovirus infection (hsa05163 )
Kaposi sarcoma-associated herpesvirus infection (hsa05167 )
Human immunodeficiency virus 1 infection (hsa05170 )
Pathways in cancer (hsa05200 )
Reactome Pathway
Glucagon signaling in metabolic regulation (R-HSA-163359 )
G-protein activation (R-HSA-202040 )
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion (R-HSA-381676 )
ADP signalling through P2Y purinoceptor 12 (R-HSA-392170 )
G beta (R-HSA-392451 )
Prostacyclin signalling through prostacyclin receptor (R-HSA-392851 )
Adrenaline,noradrenaline inhibits insulin secretion (R-HSA-400042 )
Ca2+ pathway (R-HSA-4086398 )
G alpha (q) signalling events (R-HSA-416476 )
G alpha (12/13) signalling events (R-HSA-416482 )
G beta (R-HSA-418217 )
G alpha (s) signalling events (R-HSA-418555 )
ADP signalling through P2Y purinoceptor 1 (R-HSA-418592 )
G alpha (i) signalling events (R-HSA-418594 )
G alpha (z) signalling events (R-HSA-418597 )
Glucagon-type ligand receptors (R-HSA-420092 )
Thromboxane signalling through TP receptor (R-HSA-428930 )
Vasopressin regulates renal water homeostasis via Aquaporins (R-HSA-432040 )
Thrombin signalling through proteinase activated receptors (PARs) (R-HSA-456926 )
Presynaptic function of Kainate receptors (R-HSA-500657 )
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding (R-HSA-6814122 )
G beta (R-HSA-8964315 )
G beta (R-HSA-8964616 )
Extra-nuclear estrogen signaling (R-HSA-9009391 )
GPER1 signaling (R-HSA-9634597 )
ADORA2B mediated anti-inflammatory cytokines production (R-HSA-9660821 )
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits (R-HSA-997272 )
Activation of G protein gated Potassium channels (R-HSA-1296041 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 (GNG3). [1]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 (GNG3). [2]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 (GNG3). [3]
------------------------------------------------------------------------------------

References

1 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
2 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
3 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.